United States of America
Fellowship, Infectious Diseases, Mount Sinai Medical Center, New York, NY, 1982. Residency, Internal Medicine, Mount Sinai Medical Center, New York, NY, 1980. Internship, Internal Medicine, University of Wisconsin Hospitals, Madison, WI, 1978. MD, Cornell University Medical College, New York, NY, 1977. BA, Biology, Cornell University, Ithaca, NY, 1973.
Dr. Jeffrey M. Jacobson has extensive experience in the care and investigative study of patients with HIV, hepatitis B, and hepatitis C infection. His particular focus of research has been on the immunology and immunopathogenesis of HIV infection, including vaccine and other immune- and gene-based therapies. Recently, he has been studying long-acting parenteral antibody and other therapies against HIV infection. He has chaired numerous clinical research studies involving pathogenesis, pharmacokinetics, and treatment in and outside the NIH-sponsored AIDS Clinical Trials Group (ACTG).
Antell GC, Dampier W, Aiamkitsumrit B, Nonnemacher MR, Pirrone V, et al. (2017) Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5-and X4-Associated HIV-1 Vpr Sequences. Int J Genomics 2017:4081585.
Baranoski A, Jacobson JM (2014) Prevention of Opportunistic Infections in HIV Disease. Clinical Infectious Diseases. D. Schlossberg, ed. Cambridge University Press.